WO1980000565A1 - 1,5-diazabicyclo(3.3.0)octadienedione derivatives,preparation and use thereof as fluorescent labelling agents - Google Patents

1,5-diazabicyclo(3.3.0)octadienedione derivatives,preparation and use thereof as fluorescent labelling agents Download PDF

Info

Publication number
WO1980000565A1
WO1980000565A1 PCT/US1979/000685 US7900685W WO8000565A1 WO 1980000565 A1 WO1980000565 A1 WO 1980000565A1 US 7900685 W US7900685 W US 7900685W WO 8000565 A1 WO8000565 A1 WO 8000565A1
Authority
WO
WIPO (PCT)
Prior art keywords
straight chain
alkyl
branched
group
formula
Prior art date
Application number
PCT/US1979/000685
Other languages
French (fr)
Inventor
B Pazhenchevsky
E Hershkowitz
E Kosower
Original Assignee
E Kosower
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Kosower filed Critical E Kosower
Publication of WO1980000565A1 publication Critical patent/WO1980000565A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5

Definitions

  • This invention relates to novel synthetic compositions of matter and to processes for producing same. More particularly it relates to a new class of stable heterocyclic molecules which are useful as fluorescent and phosphorescent chemical (e.g., biochemical) labeling agents.
  • fluorescent and phosphorescent chemical e.g., biochemical
  • Another object is to provide a method for producing stable, readily synthesizable compounds useful for providing fluorescent or phosphorescent chemical (e.g., biochemical) labeling agents.
  • Another object is to provide fluorescent or phosphorescent chemical (e.g., biochemical) labeling agents derived. from stable, readily synthesizable compounds, and to substances labeled with same.
  • Another object is to provide a method for producing fluorescent or phosphorescent chemical ⁇ e.g., biochemical) labeling agents from stable, readily synthesizable compounds, and substances labeled with same.
  • Yet another object is to provide methods for using substances labeled with the aforementioned fluorescent or phosphorescent labeling agents.
  • R is independently (i.e., the same or different) branched or straight chain C 1 -C 4 alkyl; R 1 is independently branched or straight chain C 1 -C 4 alkyl, phenyl or halo; R 2 is independently branched .or straight chain C 1 -C 17 alkyl, with the proviso that at least one R 2 group has a single bromo substituent on the carbon atom adjacent to the ring; and X is branched or straight chain C 1 -C 17 alkylene wherein the ring carbon and the quaternary nitrogen are attached to the same carbon atom.
  • Preferred compounds within the scope of the present invention are the syn-bimanes of formulas (I) and (III) wherein R 1 is independently branched or straight chain C 1 -C 4 alkyl or halo (i.e., chloro, bromo, fluoro, iodo) .
  • Particularly preferred compounds within the group described in the previous paragraph are those wherein both R 1 groups are identical. More particularly, preferred compounds within this group are those wherein the R 1 groups are methyl.
  • the bimane compounds of the present invention are extremely useful as chemical labeling agents which react readily with free sulfhydryl groups to afford intensely fluorescent substances when syn-bimanes are employed, and strongly phosphorescent substances when anti-bimanes are employed.
  • the subject compounds also react with substances containing primary amino groups to afford fluorescent and phosphorescent materials, although the reaction conditions required are usually more rigorous,
  • a further aspect of the present invention relates to the use of the subject compounds as fluorescent and phosphorescent labeling agents and to substances labeled with same.
  • Labeling of free sulfhydryl group-containing substances with the compounds of formulas (I), (II), (III), and (IV) can be effected under a variety of reaction conditions, including but not limited to physiologically "normal” conditions in which labeling can be rapidly effected at pH 7.4 and 25 oC in aqueous media.
  • proteins including immunoglobulins and enzymes, dyes, pigments and polymers.
  • a particularly useful application of the syn-bimanes of the instant invention is in the labeling of specific protein molecules, i.e., immunoglobulins, to afford fluorescent labeled antibodies.
  • Antigenic materials containing free sulfhydryl groups can also be labeled with the subject compounds to afford fluorescent antigens.
  • the labeled materials are extremely stable to light, air and various routine chemical pro-cedures.
  • convenient operating wavelengths can be used in measuring the extent of labeling.
  • the fluorescence of substances labeled with syn-(BrCH 2 , CH 3 )(CH 3 , CH 3 )B, syn-(BrCH 2 , CH 3 )B and syn-(BrCH 2 , CH 3 )(Br (CH 3 ) 3 N + CH 2 , CH 3 )B can be determined at an excitation wavelength of 380 nm and an emission wavelength of 480 nm.
  • the syn- and anti-bimanes of the instant invention are mutually compatible, it is possible to label a substance with both types of agent to afford a material, having fluorescence as well as phosphorescence.
  • R o is a branched or straight chain C 1 - C 1 7 alkyl group having at least one alpha hydrogen
  • Z is a suitable leaving group such as chloro or bromo and R 1 and R 2 are as previously described.
  • an appropriately substituted 2-pyrazolin-5-one (A) is treated with a weak base, to give an intermediate which reacts with its own decomposition product to produce the syn and anti isomers of formulas (B) and (C), respectively.
  • the reaction is conducted in a suitable organic solvent such as methylene chloride, acetonitrile and the like.
  • suitable bases include alkali metal carbonates (e.g., K 2 CO 3 ), bicarbonates (e.g., NaHCO 3 ) , and hydroxides (e.g., KOH, NaOH) as well as ion-exchange resins in the hydroxide form.
  • CH 3 )B can be produced by bromination of (B) wherein the R 1 and R o groups are methyl.
  • syn-(BrCH 2 , CH 3 )B can be produced by bromination of syn-(BrCH 2 CH 3 )(CH 3 ,
  • DMSO dimethylsulfoxide
  • thionyl chloride a compound prepared from the bromo compounds by treatment with wet sodium trifluoro- acetate in acetonitrile
  • the corresponding mono- and bis-fluoro compounds can be made by reaction of the aforesaid alcohols with the reagent Et 2 NSF 3 .
  • alcohols can serve as intermediates in the formation of other derivatives, e.g., tosylates.
  • Iodides may also be prepared via the reaction of alkali metal iodide (e.g., NaI) with the bromides.
  • the mixed isomers of formulas (B' ) and (C) are converted to the mono and dibromo derivatives, after separation, by reaction with stoichiometric amounts of bromine.
  • the bimanes of formulas (III) and (IV) are respectively prepared by treating syn and anti compounds of the type (R 2 , R 1 )B or (R 2 , R 1 )(R 2 ', R 1 ' ) , wherein the R 2 and R 1 groups contain a bromo substituent on the carbon atom adjacent the ring, with a C 1 -C 4 alkyl tertiary amine. Reaction is typically carried out in an organic solvent at room temperature.
  • a quantity (137.8 g) of 3,4-dimethyl-2-pyrazolin- 5-one is charged, together with 1.2 liters of 1 ,2-dichloro- ethane, into a 3-neck, 2-liter flask equipped with a gas inlet, reflux condenser, and a gas outlet which is connected to a Cl 2 trap (bisulfite solution).
  • Chlorine is introduced at a rate such that the solution gently boils and until the solid has dissolved and the solution acquires a green-yellow color.
  • the reaction mixture is then cooled to room temperature and stirred for one-half hour. There- after, air is bubbled through the system for 10 minutes to removed dissolved chlorine and the solution is filtered.
  • anti-(BrCH 2 , CH 3 )B or anti-(BrCH 2 , CH 3 )(CH 3 , CH 3 )B can be obtained, depending on the amount of bromine employed.
  • a quantity (25 mg) of gamma-immunoglobul in (IgG) is dissolved in 5 ml of a solution containing 8 M urea, 0.1% ethylenediamine tetraacetic acid and 0.2 M tris buffer at a pH of 7.5.
  • a solution of syn-(Br 2 CH 2 , CH 3 ,)B in 250 ⁇ 1 of DMSO dropwise over a period of several minutes.
  • the reaction mixture is stirred for 30 minutes, diluted to 20 ml with water and then dialyzed against 0.1 M tris buffer at pH 7.5 for 24 hours whereupon a fluorescent solution is obtained which can be used per se.
  • a greater incorporation of labeling agent can be achieved by pretreating the IgG with 1-10 molar equivalents of mercaptoethanol for one hour and then dialyzing to remove excess mercaptoethanol prior to adding the labeling agent.
  • a quantity (0.5 ml) of goat-antihuman serum is mixed with 0.5 ml of 0.5 M sodium carbonate buffer (pH 9) and 20 ⁇ I of a solution of syn-(BrCH 2 , CH 3 )B in ethanol. After five minutes at room temperature, the solution is applied to a 1 x 7 cm column of Sephadex G 25 and eluted with phosphate buffered saline (PBS). A fluorescent band of labeled immunoglobulins eluting in the void volume is collected; a larger band of unreacted syn-(BrCH 2 , CH 3 )B, emerging more slowly, is discarded.
  • PBS phosphate buffered saline
  • the collected labeled immunoglobulin fraction obtained above can be used directly in immunoassay.

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds of the formulas. (FORMULA) wherein R is independently branched or straight chain C1-C4 alkyl; R1 is independently branched or straight chain C1-C4 alkyl, phenyl or halo; R2 is independently branched or straight chain C1-C17 alkyl wherein at least one R2 group has a bromo substituent on the carbon atom adjacent to the ring; and X is branched or straight chain C1-C17 alkylene wherein the ring carbon and the quaternary nitrogen are attached to the same carbon atom are useful as chemical labeling agents which react readily with free sulfhydryl groups or primary amino groups to produce intensely fluorescent (when compounds I and III are used) and phosphorescent (when compounds II and IV are used) substances.

Description

1, 5 - DIAZABICYCLO, (3.3.0), OCTADIENEDIONE DERIVATIVES, PREPARATION AND USE THEREOF AS FLUORESCENT LABELLING AGENTS
DESCRIPTION
TECHNICAL FIELD
This invention relates to novel synthetic compositions of matter and to processes for producing same. More particularly it relates to a new class of stable heterocyclic molecules which are useful as fluorescent and phosphorescent chemical (e.g., biochemical) labeling agents.
BACKGROUND ART
A need has existed for improved chemical labeling agents, particularly biochemical labeling agents, in the form of stable, readily synthesizable molecules which undergo fluorescence or phosphorescence under appropriate and readily attainable and controllable conditions. While considerable research effort has been spent in the past on developing improved labeling agents, few if any have been produced which satisfy the foregoing requirements.
Accordingly, it is an object of the present invention to provide stable, readily synthesizable compounds useful for providing fluorescent or phosphorescent chemical (e.g., biochemical) labeling agents.
Another object is to provide a method for producing stable, readily synthesizable compounds useful for providing fluorescent or phosphorescent chemical (e.g., biochemical) labeling agents. Another object is to provide fluorescent or phosphorescent chemical (e.g., biochemical) labeling agents derived. from stable, readily synthesizable compounds, and to substances labeled with same.
Another object is to provide a method for producing fluorescent or phosphorescent chemical {e.g., biochemical) labeling agents from stable, readily synthesizable compounds, and substances labeled with same.
Yet another object is to provide methods for using substances labeled with the aforementioned fluorescent or phosphorescent labeling agents.
These and other objects of the invention as well as the advantages thereof can be had by reference to the following disclosure and claims.
DISCLOSURE OF THE INVENTION
The foregoing objects are achieved according to the present invention by the discovery of a new class of stable, isomeric heterocyclic organic molecules, namely, 1 ,5-diazabicyclo [3.3.0]octadienedione derivatives which have been found to be useful as fluorescent and phosphorescent labeling agents. More specifically, the present invention relates to compounds of the formulas:
Figure imgf000004_0001
Figure imgf000004_0002
Figure imgf000005_0001
Figure imgf000005_0002
wherein R is independently (i.e., the same or different) branched or straight chain C1-C4 alkyl; R1 is independently branched or straight chain C1-C4 alkyl, phenyl or halo; R2 is independently branched .or straight chain C1-C17 alkyl, with the proviso that at least one R2 group has a single bromo substituent on the carbon atom adjacent to the ring; and X is branched or straight chain C1-C17 alkylene wherein the ring carbon and the quaternary nitrogen are attached to the same carbon atom.
Since the novel compounds of the instant invention are quite symmetrical, we have adopted the brief name "bimane" (bi, two and manus, hand) for the basic ring system and use a shorthand notation to denote the various syn- and anti-isomers. Thus, when substitution on both sides of the molecule is identical (i.e., R1=R1; R2=R2) the notations sγn-(R2, R1)B and anti-(R2, R1)B are used to denote compounds of formulas (I) and (II), respectively. If the substitution is not identical, the notations syn-(R2, R1)(R2 , R1 )B and anti-(R2, R1)(R2 , R1 )B are used. The shorthand notations employed for compounds of formula (III) and (IV) are thus syn-(R2, R1)(Br-(R)3 N+X, R1 )B and anti-(R2, R1 ) (Br-(R)3N+X, R1 ')B, respectively. Preferred compounds within the scope of the present invention are the syn-bimanes of formulas (I) and (III) wherein R1 is independently branched or straight chain C1-C4 alkyl or halo (i.e., chloro, bromo, fluoro, iodo) .
Particularly preferred compounds within the group described in the previous paragraph are those wherein both R1 groups are identical. More particularly, preferred compounds within this group are those wherein the R1 groups are methyl.
Especially preferred compounds within the group described in the previous paragraph are:
Figure imgf000006_0001
Figure imgf000007_0001
The bimane compounds of the present invention are extremely useful as chemical labeling agents which react readily with free sulfhydryl groups to afford intensely fluorescent substances when syn-bimanes are employed, and strongly phosphorescent substances when anti-bimanes are employed. The subject compounds also react with substances containing primary amino groups to afford fluorescent and phosphorescent materials, although the reaction conditions required are usually more rigorous,
Accordingly, a further aspect of the present invention relates to the use of the subject compounds as fluorescent and phosphorescent labeling agents and to substances labeled with same.
Labeling of free sulfhydryl group-containing substances with the compounds of formulas (I), (II), (III), and (IV) can be effected under a variety of reaction conditions, including but not limited to physiologically "normal" conditions in which labeling can be rapidly effected at pH 7.4 and 25 ºC in aqueous media.
In view of the myriad of naturally occurring and synthetic substances containing free sulfhydryl groups, the range of substances capable of being labeled with the subject compounds is extensive. Representative examples of such substances include, but are not limited to, cells
(e.g., red blood cells, lymphocytes, fibroblasts) , proteins including immunoglobulins and enzymes, dyes, pigments and polymers.
In using the syn-bimane compounds for labeling normal human erythrocytes, it has been found that the non-ionic compounds of formula (I) penetrate cell membranes very readily while the ionic compounds of formula (III) do not. Specifically, it has been found that globin and membrane proteins are labeled by both mono- and bis-bromo syn-bimanes (I) after addition of the agents to intact red cells; neither membrane proteins nor globin is labeled when intact cells are treated with a mono- quaternary syn-bimane (III); and both membrane proteins and globin are labeled by (III) after lysis. Only the beta chains of the globin are labeled, the primary labeling site being beta93 cysteine. Another labeled compound within the cell is glutathione.
A particularly useful application of the syn-bimanes of the instant invention is in the labeling of specific protein molecules, i.e., immunoglobulins, to afford fluorescent labeled antibodies. Antigenic materials containing free sulfhydryl groups can also be labeled with the subject compounds to afford fluorescent antigens.
In addition to the foregoing applications, it has been found that both syn- and anti-bimanes are effective in producing labeled polymers, dyes and pigments. There are several important advantages to bimane labeled substances prepared according to the invention.
For example, in addition to being intensely fluorescent or phosphorescent, the labeled materials are extremely stable to light, air and various routine chemical pro-cedures. Moreover, convenient operating wavelengths can be used in measuring the extent of labeling. For instance, the fluorescence of substances labeled with syn-(BrCH2, CH3)(CH3, CH3)B, syn-(BrCH2, CH3)B and syn-(BrCH2, CH3)(Br (CH3)3N+CH2, CH3)B can be determined at an excitation wavelength of 380 nm and an emission wavelength of 480 nm. Also, since the syn- and anti-bimanes of the instant invention are mutually compatible, it is possible to label a substance with both types of agent to afford a material, having fluorescence as well as phosphorescence.
In a further aspect of the present invention, the following description relates to the synthesis of the novel bimanes of formulas (I), (II), (III), and (IV).
The bimanes of formulas (I) and (II), wherein R1 is the same on both rings, are prepared according to the following synthetic method and postulated reaction mechanism:
Figure imgf000010_0001
wherein Ro is a branched or straight chain C1- C 1 7 alkyl group having at least one alpha hydrogen, Z is a suitable leaving group such as chloro or bromo and R1 and R2 are as previously described.
In the foregoing reaction sequence, an appropriately substituted 2-pyrazolin-5-one (A) is treated with a weak base, to give an intermediate which reacts with its own decomposition product to produce the syn and anti isomers of formulas (B) and (C), respectively. Typically, the reaction is conducted in a suitable organic solvent such as methylene chloride, acetonitrile and the like. Suitable bases include alkali metal carbonates (e.g., K2CO3), bicarbonates (e.g., NaHCO3 ) , and hydroxides (e.g., KOH, NaOH) as well as ion-exchange resins in the hydroxide form.
The thus obtained mixed syn and anti isomers of formulas (B) and (C) respectively are converted to mono- or dibromo derivatives, preferably after separation, by reaction with stoichiometric amounts of bromine or other brominating agent. For example, syn-(BrCH2, CH3)(CH3,
CH3)B can be produced by bromination of (B) wherein the R1 and Ro groups are methyl. Similarly, syn-(BrCH2, CH3)B can be produced by bromination of syn-(BrCH2 CH3)(CH3,
CH3)B. In a further embodiment, the foregoing mono- or dibromo derivatives can be converted to their chloro analogs by (a) displacement of Br- with Cl- using LiCl in
DMSO (dimethylsulfoxide) with warming or (b) facile reaction of the corresponding alcohols (prepared from the bromo compounds by treatment with wet sodium trifluoro- acetate in acetonitrile) with thionyl chloride. Also, the corresponding mono- and bis-fluoro compounds can be made by reaction of the aforesaid alcohols with the reagent Et2NSF3.
Furthermore, the alcohols can serve as intermediates in the formation of other derivatives, e.g., tosylates. Iodides may also be prepared via the reaction of alkali metal iodide (e.g., NaI) with the bromides.
When two different 2-pyrazolin-5-ones are employed in the preparation of compounds of formulas (I) and (II), mixed syn and anti isomers are produced as follows:
Figure imgf000012_0001
The mixed isomers of formulas (B' ) and (C) are converted to the mono and dibromo derivatives, after separation, by reaction with stoichiometric amounts of bromine.
The bimanes of formulas (III) and (IV) are respectively prepared by treating syn and anti compounds of the type (R2, R1 )B or (R2, R1)(R2', R1 ' ) , wherein the R2 and R1 groups contain a bromo substituent on the carbon atom adjacent the ring, with a C1-C4 alkyl tertiary amine. Reaction is typically carried out in an organic solvent at room temperature.
DESCRIPTION OF PREFERRED EMBODIMENTS
The following examples are provided for the purpose of illustrating, without limitation, the present invention and the advantages thereof. In the examples, the pyrazolinone starting materials are available by synthetic procedures and methods well known in the art. Structures of the products can be confirmed using the methods and procedures described in JACS, 100, 6516-8 (1978) and JACS, 101, 1620-1 (1979).
Preparation of 3,4-dimethyl-4-chloro-2-pyrazolin-5-one
A quantity (137.8 g) of 3,4-dimethyl-2-pyrazolin- 5-one is charged, together with 1.2 liters of 1 ,2-dichloro- ethane, into a 3-neck, 2-liter flask equipped with a gas inlet, reflux condenser, and a gas outlet which is connected to a Cl2 trap (bisulfite solution). Chlorine is introduced at a rate such that the solution gently boils and until the solid has dissolved and the solution acquires a green-yellow color. The reaction mixture is then cooled to room temperature and stirred for one-half hour. There- after, air is bubbled through the system for 10 minutes to removed dissolved chlorine and the solution is filtered. Evaporation of the filtrate affords a white oil which is taken up in 300 ml of hot solvent (1:1 benzene :petroleum ether), upon cooling the solution, 110.7 g of crystalline 3,4-dimethyl-4-chloro-2-pyrazolin-5-one precipitates and is collected by filtration. Evaporation of the filtrate and further cooling yields an additional 21 g of product, m.p. 56 C.
Example I
Preparation of Syn- And Anti- (BrCH2, CH3)B and (BrCH2, CH3)(CH3, CH3)B
A quantity (70 g, 0.48 mole) of 3,4-dimethyl-4- chloro-2-pyrazolin-5-one, produced according to the foregoing recitation, is dissolved in 500 ml of methylene chloride and the resulting solution is added over a period of 1-2 minutes to a cooled (ice bath), vigorously stirred mixture of 150 g of K2CO3 . 1/2 H2O, 50 g of anhydrous K2CO3 and 250 ml of methylene chloride. After one hour, the ice bath is removed and stirring is continued at room temperature for 18 hours. During this period, the crystalline K2CO3 . 1/2 H2O becomes suspended in finely divided form. Celite (powdered diatomaceous earth; 50 g) is added and the mixture is filtered with suction through a celite layer approximately 5 mm thick. Evaporation of the yellow filtrate yields a solid yellow residue which is dissolved in the smallest possible volume (ca. 150 ml) of boiling acetonitrile. Upon cooling to room temperature, 27.5 g of syn-(CH3, CH3)B is deposited. Further cooling yields more precipitate which contains a small amount of anti-(CH3, CH3)B. Recrystallization of this fraction from acetonitrile yields 2.5 g of syn-(CH3, CH3)B, m.p. 211-212ºC. The filtrate is evaporated and the residue taken up in methylene chloride and partitioned by column chromatography (150 g activity grade neutral alumina) using 2 or 3 elutions with methylene chloride. In order of elution, 2.1 g of anti-(CH3, CH3)B and 1.6.g of syn-(CH3, CH3)B are obtained.
A quantity (1.92 g; 0.005 mole) of syn-(CH3, CH3)B is dissolved in 50 ml of methylene chloride and thereafter 2.56 g (0.021 mole) of bromine in 25 ml of methylene chloride is added dropwise to the bimane solution over a period of 1 hour. When approximately 1/2 of the bromine solution has been added, a white precipitate appears which redissolves toward the end of the addition. Approximately 1/2 the reaction solution is then evaporated leaving a red oil which is dissolved in hot ethyl acetate. On cooling to room temperature, the product precipitates to afford 2.56 g of syn-(BrCH2, CH3)B, m.p. 176-178ºC.
The use of 1.28 g (0.010 mole) of bromine in the foregoing bromination procedure produces syn-(BrCH2, CH3)(CH3, CH3)B.
Moreover, when syn-(CH3, CH3)B is replaced with anti-(CH3, CH3)B in the foregoing procedure, anti-(BrCH2, CH3)B or anti-(BrCH2, CH3)(CH3, CH3)B can be obtained, depending on the amount of bromine employed.
Example II
Using the appropriate 2-pyrazoline-5-ones in the procedure of Example I, the following representative monobromo and dibromo syn and anti-bimanes are obtained:
Figure imgf000016_0001
Figure imgf000016_0002
Example III
Preparation of Syn-(BrCH2, CH3) (Br-(CH3)3N+CH2, CH3)B
Ten grams of syn-(BrCH2, CH3)B prepared according to Example I, is dissolved in 150 ml of chloroform and 8.1 ml of 25% trimethylamine in methanol is then added to the solution. After stirring the reaction mixture at room temperature for 2 hours, the product is collected by filtration and dried under vacuum to afford 11 g of syn-(BrCH2, CH3 ) (Br-(CH3)3N+CH2, CH3)B.
The foregoing procedure can be used for the preparation of all compounds of formulas III and IV when appropriate reactants are employed.
Example IV
The following example illustrates the use of a representative bimane of the instant invention as a fluorescent labeling agent.
A quantity (25 mg) of gamma-immunoglobul in (IgG) is dissolved in 5 ml of a solution containing 8 M urea, 0.1% ethylenediamine tetraacetic acid and 0.2 M tris buffer at a pH of 7.5. To this solution is added a solution of syn-(Br2CH2, CH3,)B in 250μ1 of DMSO dropwise over a period of several minutes. After the addition is complete, the reaction mixture is stirred for 30 minutes, diluted to 20 ml with water and then dialyzed against 0.1 M tris buffer at pH 7.5 for 24 hours whereupon a fluorescent solution is obtained which can be used per se. A greater incorporation of labeling agent can be achieved by pretreating the IgG with 1-10 molar equivalents of mercaptoethanol for one hour and then dialyzing to remove excess mercaptoethanol prior to adding the labeling agent.
Example V
The following example illustrates additional labeling of immunoglobulins with a representative compound of the instant invention.
A quantity (0.5 ml) of goat-antihuman serum is mixed with 0.5 ml of 0.5 M sodium carbonate buffer (pH 9) and 20 μI of a solution of syn-(BrCH2, CH3)B in ethanol. After five minutes at room temperature, the solution is applied to a 1 x 7 cm column of Sephadex G 25 and eluted with phosphate buffered saline (PBS). A fluorescent band of labeled immunoglobulins eluting in the void volume is collected; a larger band of unreacted syn-(BrCH2, CH3)B, emerging more slowly, is discarded.
The collected labeled immunoglobulin fraction obtained above can be used directly in immunoassay.
The foregoing examples are provided for illustrative purposes only. It is understood than changes and variations can be made therein without departing from the scope of the present invention which is defined in the following claims.

Claims

Claims :
1. A 1 ,5-diazabicyclo[3.3.0]octadienedione having a formula selected from the group consisting of:
Figure imgf000019_0001
Figure imgf000019_0002
wherein R. is independently branched or straight chain C1-C4 alkyl; R1 is independently branched or straight chain C1-C4 alkyl, phenyl or halo; R2 is independently branched or straight chain C1-C17 alkyl wherein at least one R2 group has a bromo substituent on the carbon atom adjacent to the ring; and X is branched or straight chain C1-C17 alkylene wherein the ring carbon and the quaternary nitrogen are attached to the same carbon atom.
2. A compound according to claim 1 having the formula
(I) wherein R1 is independently branched or straight chain C1-C4 alkyl or halo.
3. A compound according to claim 2 wherein both R1 groups are identical.
4. A compound according to claim 3 wherein both R1 groups are methyl.
5. The compound according to claim 4 having the formula:
Figure imgf000020_0001
6. The compound according to claim 4 having the formula:
Figure imgf000020_0002
7. A compound according to claim 1 having the formula (III) wherein R1 is independently branched or straight chain C1-C4 alkyl or halo.
8. A compound according to claim 7 wherein both R1 groups are identical.
9. A compound according to claim 8 wherein both R1 groups are methyl.
10. The compound according to claim 9 having the formula:
Figure imgf000021_0001
11. A process for preparing a compound having a formula selected from the group consisting of:
Figure imgf000021_0002
Figure imgf000021_0003
wherein R1 is independently branched or straight chain C1-C4 alkyl, phenyl or halo and R2 is independently branched or straight chain C1-C17 alkyl wherein at least one R2 group has a bromo substituent on the carbon atom adjacent to the ring, said process comprising:
(a) reacting a base with a pyrazolinone of the formula:
Figure imgf000022_0001
wherein RO is branched or straight chain C1-C17 alkyl, having at least one alpha hydrogen, and Z is a leaving group; and
(b) reacting the product of step (a) with bromine.
12. A process according to Claim 11 wherein the base used in step (a) is selected from the group consisting of alkali metal carbonates, alkali metal bicarbonates, alkali metal hydroxides and ion exchange resins in the hydroxide form.
13. A process for preparing a compound having a formula selected from the group consisting of:
Figure imgf000022_0002
Figure imgf000022_0003
wherein R is independently branched or straight chain C1-C4 alkyl; R1 is independently branched or straight chain C1-C4 alkyl, phenyl or halo; R2 is independently branched or straight chain C1-C17 alkyl having a bromo substituent on the carbon atom adjacent to the ring; and X is branched or straight chain C1-C17 alkylene wherein the ring carbon and the quaternary nitrogen are attached to the same carbon atom, said process comprising reacting a compound selected from the group represented by the formulas:
Figure imgf000023_0004
Figure imgf000023_0001
with a C1-C4 alkyl tertiary amine of the formula N(R)3.
14. A fluorescent antibody consisting essentially of an immunoglobulin coupled by a free sulfhydryl group to a compound having a formula selected from the group consisting of:
Figure imgf000023_0002
Figure imgf000023_0003
wherein R is independently branched or straight chain C1-C4 alkyl; R1 is independently branched or straight chain C1-C4 alkyl, phenyl or halo; R2 is independently branched or straight chain C1-C17 alkyl wherein at least one R2 group has a bromo substituent on the carbon atom adjacent to the ring; and X is branched or straight chain C1-C17 alkylene wherein the ring carbon and the quaternary nitrogen are attached to the same carbon atom.
PCT/US1979/000685 1978-09-05 1979-09-04 1,5-diazabicyclo(3.3.0)octadienedione derivatives,preparation and use thereof as fluorescent labelling agents WO1980000565A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93891878A 1978-09-05 1978-09-05
US938918 1978-09-05
US6854479A 1979-08-27 1979-08-27

Publications (1)

Publication Number Publication Date
WO1980000565A1 true WO1980000565A1 (en) 1980-04-03

Family

ID=26749081

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1979/000685 WO1980000565A1 (en) 1978-09-05 1979-09-04 1,5-diazabicyclo(3.3.0)octadienedione derivatives,preparation and use thereof as fluorescent labelling agents

Country Status (3)

Country Link
EP (1) EP0018991A4 (en)
JP (1) JPS55500638A (en)
WO (1) WO1980000565A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2569412A (en) * 2017-06-04 2019-06-19 Neogi Ishita Preparation of bimanes and chlorination of pyrazolinones

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Acta Chemica Scandinavica, Vol. 27, No. 2, issued 1973 (Copenhagen), pp. 661-669, I. Sotofte, "The Crystal Structure of 2-Bromo-1-methyl-benzo(c)-pyrazolo (1:2a) pyrazole-3:9-dione and 3-Bromo-2-methyl-pyrazolo-(a) (3,1)benzoxazin-5-one". *
Chemistry and Industry, issued January 1957 (London), p. 17, W.L. MOSBY, "The Structure of Heller's Bisanthranil". *
Journal of The American Chemical Society Vol. 101, No. 6, issued March, 1979 (Easton, Pennsylvania), pp. 1620-21, E.M. KOSOWER et al, "Configuration and Planarity of Fluorescent and Non-fluorescent 1,5-Diazabicyclo(3.3.0)-octadienediones (9,10-dioxabimanes) by X-ray Crystallography". *
Journal of The American Chemical Society, Vol. 100, No. 20 issued September 1978 (Easton, Pennsylvania), pp. 6516-18, E.M. KOSOWER et al. "1,5-Diazabicyclo(3.3.0) octadienediones (9,10-dioxabimanes). Strongly Fluorescent Syn Isomers". *
Journal of The American Chemical Society, Vol. 80, issued February 1958 (Easton, Pennsylvania), pp. 599-601, L.A. CARPINO, "A New Synthesis of Unsaturated Acids. I. alpha, beta-Acetylenic Acids". *
Journal of The Chemical Society (London) Perkin Transactions I, issued 1973, pp. 221-25, C.W. REES et al, "Reactive Intermediates. Part XXI. Thermal Decarboxylation of 2, 6-Diazatricyclo(5,2,1,02,6)-deca-4,8-diene-3,10-diones to pyrazolo (1,5-a)-pyridines". *
Journal of The Chemical Society (London), Section C, issued 1967, pp. 1792-95, G.K.J. GIBSON et al, "The Relationship of Bisanthranil to its Structural Isomer and Related Compounds". *
N.S. KOSOWER et al, Abstract and charts presented at Biophysics Congress, Kyoto, Japan, September 1978. "Syn-Bimane Bromides, A New Series of Fluorescent Labeling Agents". *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2569412A (en) * 2017-06-04 2019-06-19 Neogi Ishita Preparation of bimanes and chlorination of pyrazolinones
GB2569412B (en) * 2017-06-04 2020-04-01 Neogi Ishita Chlorination of pyrazolinones

Also Published As

Publication number Publication date
JPS55500638A (en) 1980-09-11
EP0018991A4 (en) 1981-03-24
EP0018991A1 (en) 1980-11-26

Similar Documents

Publication Publication Date Title
US6054271A (en) Methods of using synthetic molecules and target sequences
US4830786A (en) Squaraine dyes
US5932474A (en) Target sequences for synthetic molecules
US6008378A (en) Synthetic molecules that specifically react with target sequences
EP0180492B1 (en) Macropolycyclic complexes of rare earth metals and application as fluorescent labels
US5416214A (en) Squaraine dyes
Dickens et al. Transition metal mediated thiation of aromatic rings
EP1032837B1 (en) Target sequences for synthetic molecules and methods of using same
Krespan et al. Perfluoroallyl fluorosulfate, a reactive new perfluoroallylating agent
HU208317B (en) Process for producing mono-n-alkylated polyaza-macrocyclic compounds
EP0206241A1 (en) Process for the preparation of cis-5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-indene-3-acetic acid
US4499284A (en) 1,5-Diazabicyclo [3.3.0.]octadienediones
EP0103961B1 (en) Allyloxy- and allylthio-2,3,4,5-tetrahydro-1h-3-benzazepines
US2937186A (en) Isothiocyanate compounds and means of producing the same
WO1980000565A1 (en) 1,5-diazabicyclo(3.3.0)octadienedione derivatives,preparation and use thereof as fluorescent labelling agents
EP0168119A1 (en) Chemiluminescent substituted epidoxy-polycycloalkyl polycycloalkanes and process for preparing these compounds
Picotin et al. Reaction of allylic aluminum reagents with 1, 3-dithienium tetrafluoroborate and with 2-chloro-1, 3-dithiane: preparation of 2-substituted 1, 3-dithianes
Moss et al. Novel Preparation of Cyanophenylcyclopropanes Via Cyanophenylcarbene
US2726264A (en) Alpha-halogenosulfamylacetophenones
JPS6392647A (en) Novel thyronine derivative
EP0053915B1 (en) Novel compounds and hapten-immunoglobulin conjugates derived from them
Fellman et al. Communications-Some New Reactions of Nitrogen Iodide with Organic Compounds
JPS63246382A (en) Biotinyl reagent and biotinylation using said reagent
Suzuki et al. A novel synthesis of alkyl aryl sulfones via the telluride ion-assisted coupling of arenesulfonyl chlorides with alkyl halides
US5319143A (en) Bis(aminoethanethiols)

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): CH DE GB JP

AL Designated countries for regional patents

Designated state(s): CH DE FR GB